Territorial Availability: Available through Bertin Technologies only in France
- Synonyms
- myo-inositol, 1,2,3,4,5,6-hexakis(dihydrogen phosphate), hexasodium salt
- Correlated keywords
- 83-86-3 14306-25-3 333723-30-1 anti-oxidant antinutrient SNF-472 SNF472 phytate inositol-6-phosphate
- Product Overview:
D-myo-Inositol-1,2,3,4,5,6-hexaphosphate (IP6) is a phosphate ester of inositol. It is found in mammalian cells and undergoes interconversion to other forms of inositol phosphate that act as second messengers in cell signaling.{48091} IP6 is an antioxidant that chelates iron at a molar ratio of 1:4 to reduce iron-induced hydroxy radical production and lipid peroxidation in cell-free assays.{48092} It also inhibits the formation of thiobarbituric acid reacting substances (TBARS) in cooked chicken breast when used at a concentration of 1.5 mM. IP6 inhibits proliferation of a variety of cancer cells in vitro and reduces tumor growth in rodent xenograft models.{48093} It is also known as phytic acid and is considered an anti-nutrient that binds minerals, including calcium, iron, magnesium, and zinc, in grains, legumes, oilseeds, nuts, and other plants and prevents their absorption in the gastrointestinal tract of humans and animals that ingest them.{48091} Formulations containing IP6 have been used in cosmetics and as preservatives in food production. Cayman’s IP6 is a highly purified product intended for use in biomedical research applications.
Cayman Chemical’s mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.